Walleye Capital’s CVS Health CVS Stock Holding History

Walleye Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$65.4K	Sell	911 -175,482	-99%	-$13.5M	﹤0.01%	3820
2025 Q4	$14M	Sell	176,393 -10,942	-6%	-$863K	0.04%	449
2025 Q3	$14.1M	Buy	187,335 +77,906	+71%	+$5.34M	0.05%	392
2025 Q2	$7.55M	Buy	109,429 +106,715	+3,932%	+$7M	0.03%	639
2025 Q1	$184K	Sell	2,714 -78,973	-97%	-$4.73M	﹤0.01%	3328
2024 Q4	$3.67M	Buy	81,687 +81,121	+14,332%	+$4.55M	0.01%	1292
2024 Q3	$35.6K	Sell	566 -244,025	-100%	-$14.2M	﹤0.01%	4713
2024 Q2	$14.4M	Buy	244,591 +76,234	+45%	+$4.77M	0.03%	534
2024 Q1	$13.4M	Buy	168,357 +145,473	+636%	+$11.1M	0.02%	645
2023 Q4	$1.81M	Buy	+22,884	New	+$1.63M	﹤0.01%	1866
2023 Q2	–	Sell	-22,163	Closed	-$1.58M	–	4411
2023 Q1	$1.65M	Buy	+22,163	New	+$1.86M	0.02%	844
2022 Q4	–	Sell	-28,800	Closed	-$2.78M	–	3264
2022 Q3	$2.75M	Buy	+28,800	New	+$2.85M	0.05%	416
2021 Q4	–	Sell	-2,436	Closed	-$207	–	2142
2021 Q3	$207	Buy	+2,436	New	+$204K	0.01%	1180

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Walleye Capital's CVS Position: Q1 2026 in Review

Walleye Capital reduced its CVS Health (CVS) stake by 99% in Q1 2026, selling an estimated $13.5M and leaving 911 shares worth $65.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3820.

Walleye Capital first reported a position in CVS in Q3 2021 and has held it in 13 quarters since. The position peaked at $14.4M in Q2 2024. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Walleye Capital held 911 shares of CVS Health worth $65.4K as of Q1 2026.
Walleye Capital sold 175,482 CVS Health shares in Q1 2026, an estimated $13.5M.
CVS Health made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3820 holding.
Walleye Capital first reported a position in CVS Health in Q3 2021 and has held it in 13 quarters since.
Walleye Capital's CVS Health position peaked at $14.4M in Q2 2024.
1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.